Meloxicam, Paracetamol & Serratiopeptidase Veterinary Bolus

Formulated specifically for veterinary care, this powerful bolus combines Meloxicam (100mg), Paracetamol (1500mg), and Serratiopeptidase (100mg) to provide comprehensive relief from pain, inflammation, swelling, and fever. Ideal for cattle, sheep, goats, and other farm animals suffering from joint issues, musculoskeletal disorders, mastitis, or post-operative conditions. Packaged in a convenient 1x2 bolus blister pack for easy administration and potent therapeutic action.

Meloxicam, Paracetamol & Serratiopeptidase Veterinary Bolus is a combination veterinary formulation containing three active ingredients that provide complementary analgesic, anti-inflammatory, antipyretic and supportive therapeutic actions. It is designed to help manage pain, inflammation, swelling and fever associated with selected veterinary conditions, subject to the approved composition and target animal species. Meloxicam belongs to the non-steroidal anti-inflammatory drug (NSAID) group and works by inhibiting cyclooxygenase enzymes, particularly COX-2, thereby reducing the production of prostaglandins responsible for pain, inflammation and swelling. It helps relieve inflammatory discomfort and may improve mobility in animals experiencing musculoskeletal pain and inflammatory conditions. Paracetamol acts primarily as an analgesic and antipyretic agent, helping reduce pain and elevated body temperature through its central mechanisms of action. It complements the anti-inflammatory activity of meloxicam by providing additional pain and fever relief. Serratiopeptidase is a proteolytic enzyme that is used in certain formulations for its potential role in supporting the management of inflammatory swelling and tissue oedema by breaking down protein components associated with inflammatory exudates. Together, these ingredients are intended to provide multi-action support in conditions involving pain, inflammation, swelling and fever. Depending on the approved veterinary formulation, the combination may be considered for supportive management of selected musculoskeletal and inflammatory conditions, post-traumatic discomfort and other painful conditions in livestock. The bolus dosage form is designed for convenient oral administration and may be particularly suitable for larger animals when an appropriate species-specific dose is prescribed. Its use should be based on the animal's body weight, clinical condition, diagnosis and veterinary assessment. Possible adverse effects may include reduced appetite, vomiting, diarrhoea, gastrointestinal irritation, stomach ulceration and kidney-related complications due to NSAID use. Excessive paracetamol administration may cause serious liver toxicity, while special care is required in dehydrated animals and those with existing kidney or liver disorders. The product should not be combined with other NSAIDs or paracetamol-containing medicines unless specifically advised by a veterinarian. The exact ingredient strengths, target animal species, safety profile and approved therapeutic indications should be verified against the final product formulation before marketing or administration. This veterinary bolus should be administered only under veterinary supervision, according to the recommended dosage and approved product label, with appropriate attention to treatment duration and applicable meat and milk withdrawal periods in food-producing animals.